Orion Pharma pens €100m EIB loan
EIB has lent €100 million ($117.88 million) to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other...
EIB has lent €100 million ($117.88 million) to Finnish pharmaceutical company Orion Pharma to develop new treatments for cancer, pain and other...